
Back Pain
Christopher Wise, M.D., F.A.C.P.
Medical College of Virginia at Virginia Commonwealth University
Definition/Key Clinical Features
Differential Diagnosis
Best Tests
Best Therapy
Best References
Definition/Key Clinical Features
- Usually aching pain in lower lumbar or sacroiliac area, worse with movement, relieved with rest and lying down
Differential Diagnosis
- Lumbar spinal stenosis
- Neoplasm
- Infection
- Other lesions
Best Tests
Acute Back Pain
- History and physical exam to identify risk factors [see Red Flags, below] and bony tenderness pain with straight-leg raising; assessment for loss of sensation or strength
- Further evaluation usually unnecessary in patients without red flags, because acute low back pain improves in 1 mo in > 90% of cases
- Reserve plain radiographs for high-risk patients
Persistent Back Pain
- Reassess if pain persists after 4–6 wk of conservative treatment
- Obtain plain radiographs and basic lab studies (CBC, ESR, chemistry profile, U/A) to screen for systemic illness
MRI to confirm herniated disk or to evaluate for lumbar spinal
stenosis, neoplasm, infection, other lesions
- Electromyography in selected patients; useful in differentiating lumbar
radiculopathy from other causes of radicular leg pain
- Myelogram–CT scanning in selected patients to confirm lumbar stenosis
Test Comparison
- MRI: confirms herniated disk or other osseous or soft tissue lesions; many
false positives in unselected patients with nonradicular pain
- Sensitivity: high for herniation and spinal stenosis
- Specificity: high false positive rate in asymptomatic patients (bulge
in 20%–80%, herniation in 20%–40%, spinal stenosis in 20%
older than 60 yr)
- Electromyography: useful in differentiating lumbar radiculopathy from other
causes of radicular leg pain
- Sensitivity: uncertain
- Specificity: uncertain
- Myelogram–CT scanning: useful in selected cases of lumbar stenosis or
other selected conditions, most useful in selected cases for planning surgery
- Sensitivity: similar to MRI
- Specificity: similar to MRI
Red Flags
- Indications that acute back pain may involve serious underlying conditions
- Patient demographics
- Age > 70 yr
- History of cancer
- Glucocorticoid therapy or immunosuppressive drug therapy
- Alcohol or I.V. drug use
- Historical features
- Weight loss
- Fever
- Pain increased by rest
- Neurologic symptoms
- Bowel or bladder dysfunction
- Saddle-block anesthesia
- Progressive motor weakness
Best Therapy
Acute Back Pain
- Avoid strict bed rest (at most 2–4 days)
- Continue normal activities within limits permitted by pain
- Mild analgesics and NSAIDs
- Use muscle relaxants and opiates sparingly
- Further studies (MRI, CT) indicated in patients with persistent sciatica or progressive pain
- Surgery indicated in patients with radicular symptoms and clear-cut evidence of herniated disk correlating with symptoms
Persistent Back Pain
- Physical therapy with local modalities, exercise program, patient-education program emphasizing proper ergonomics for lifting and other activities
- Encourage light normal activity and regular walking program
- Use analgesics, NSAIDs, and TCAs judiciously
- Consider further studies (MRI, CT) and consider surgical decompression by multilevel laminectomy and fusion for patients with herniated disk or spinal stenosis and progressive functional deterioration
Analgesics and NSAIDs Comparison
- Nonopiate analgesics: safest options; moderate efficacy
- Acetaminophen
- Dose: 650–1,000 mg t.i.d.–q.i.d.
- Tramadol
- Dose: 50–100 mg q.i.d.
- Cost/mo: $70 (50 mg)
- Nonselective COX inhibitors: caution with renal disease, cardiovascular
disease, edema, risk factors for peptic ulcer disease; moderate efficacy
- Ibuprofen
Dose: 400–800 mg t.i.d.
- Cost/mo: $10 (800 mg)
- Naproxen
- Dose: 500 mg b.i.d.
- Cost/mo: $20
- Diclofenac
- Dose: 75 mg b.i.d.
- Cost/mo: $30
- COX-2 specific inhibitor: safer than nonselective COX inhibitors regarding
GI risk; used with caution with renal disease, cardiovascular disease, edema;
moderate efficacy
- Celecoxib (Celebrex)
- Dose: 200 mg b.i.d.
- Cost/mo: $150
- Opiates: may cause constipation, sedation; potentially habit forming, use
sparingly; most used in combination form with acetaminophen; moderate efficacy
- Propoxyphene
- Dose: 100 mg q.i.d.
- Cost/mo: $30
- Codeine
- Dose: 30 mg q.i.d.
- Cost/mo: $30
- Hydrocodone
- Dose: 10 mg q.i.d.
- Cost/mo: $60
- Oxycodone
- Dose: 5 mg q.i.d.
- Cost/mo: price not available
Muscle Relaxants Comparison
- Muscle relaxants: may cause drowsiness, dizziness; use for limited time
in most patients (1–2 wk); mild to moderate efficacy
- Carisoprodol
- Dose: 350 mg t.i.d.–q.i.d.
- Cost/mo: $30 (t.i.d.)
- Cyclobenzaprine
- Dose: 10 mg t.i.d.
- Cost/mo: $15
- Methocarbamol
- Dose: 1,500 mg q.i.d.
- Cost/mo: $20
- Chlorzoxazone
- Dose: 500 mg q.i.d.
- Cost/mo: $40
- Metaxalone
- Dose: 800 mg q.i.d.
- Cost/mo: $215
- Tizanadine
- Dose: 8 mg t.i.d.
- Cost/mo: $160
TCA Comparison
- TCAs: More appropriate for chronic pain; caution regarding drowsiness,
urinary retention, orthostatic hypotension, dry mouth; moderate efficacy
- Amitriptyline
- Dose: 10–100 mg q.h.s.
- Cost/mo: $10
- Nortriptyline
- Dose: 10–100 mg q.h.s.
- Cost/mo: $10
- Desipramine
- Dose: 10–100 mg q.h.s.
- Cost/mo: $10
- Doxepin
- Dose: 10–100 mg q.h.s.
- Cost/mo: $9
- Imipramine
- Dose: 10–100 mg q.h.s.
- Cost/mo: $20
Best References
Amundsen T, et al: Spine 25:1424, 2000 [PMID 10828926]
Green S, et al: BMJ 316:354, 1998 [PMID 9487172]
Mannion AF, et al: Rheumatology (Oxford) 40:772, 2001 [PMID 11477282]
August 2006